A system biology study of BALF from patients affected by idiopathic pulmonary fibrosis (IPF) and healthy controls

In conclusion, the combination of proteomic data with system biology platforms allowed us to amplify the information obtained processing the results and indicated the principal pathways involved. These information can point to potential biomarkers and new therapeutic targets opening the way for further analysis.